Intuitive Surgical (ISRG): Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase $1K–$15K
Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase of Intuitive Surgical in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 14 days
- Disclosure lag
- Traded
- Jan 30, 2026
- Disclosed
- Feb 13, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 18, 2025CongressDisclosed purchase of ISRG — reported range $1,001 - $15,000
- Dec 1, 2025Insider · 2 peopleInsiders: 2 sales (~$13.1M)
- Dec 9, 2025FDARecall: Brand Name: da Vinci S, Si Permanent Cautery Hook Instrument Product Name: da Vinci S, Si Permanent Cautery Hook Instrument Model/Catalog Number: 420183 Softwa…
- Dec 9, 2025FDARecall: Brand Name: da Vinci S, Si Mega Needle Driver Instrument Product Name: da Vinci S, Si Mega Needle Driver Instrument Model/Catalog Number: 420194 Software Versi…
- Dec 10, 2025InsiderOfficer sold ~$58K of ISRG shares in the open market
- Dec 10, 2025CongressDisclosed purchase of ISRG — reported range $1,001 - $15,000
- Dec 12, 2025InsiderOfficer sold ~$171K of ISRG shares in the open market
- Dec 15, 2025FDAFDA device clearance: da Vinci SP Surgical System (SP1098)
- Dec 15, 2025FDARecall: da Vinci SP, SP Access Port Kit, Large Incision Reference Numbers:430073 (2.7-4cm,SP1098, Box) & 430075 (2.7-7cm,SP1098,Box)
- Dec 15, 2025InsiderOfficer sold ~$254K of ISRG shares in the open market
- Dec 16, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective January 1, 2026, Brian E. Miller, Ph.D., will transition from his role as Chief Digital Officer of Intuitive Surgical, Inc. (the “Company”) and begin serving as Head of Digital and AI Strategy of the Company.”
- Dec 16, 2025FDAFDA device clearance: IRISeg
- Dec 29, 2025CongressDisclosed purchase of ISRG — reported range $15,001 - $50,000
- Dec 30, 2025FDARecall: da Vinci 5 Surgeon Console Viewer Display, ASSY, DV5 CONSOLE, IS5000, Part Number: 380730-45
- Jan 14, 2026Company filing · Form 8-K · ResultsReported its results
- Jan 16, 2026FDAFDA device clearance: da Vinci Surgical System (IS5000)
- Jan 16, 2026FDAFDA device clearance: da Vinci SP Surgical System (SP1098); da Vinci E-200 Generator
- Jan 22, 2026Company filing · Form 8-K · ResultsReported its results
- Jan 27, 2026Insider · 2 peopleInsiders: 5 sales (~$14.6M)
- Jan 29, 2026InsiderOfficer sold ~$66K of ISRG shares in the open market
- Jan 30, 2026 · this disclosureCongressDisclosed purchase of ISRG — reported range $1,001 - $15,000
What came next
- Feb 10, 2026InsiderOfficer sold ~$52K of ISRG shares in the open market
- Feb 11, 2026Insider · 2 peopleInsiders: 2 sales (~$274K)
- Feb 24, 2026FDAFDA device clearance: Universal Seal (5-12 mm)
- Feb 27, 2026Insider · 3 peopleInsiders: 3 sales (~$1.4M)
- Mar 2, 2026InsiderOfficer sold ~$62K of ISRG shares in the open market
- Mar 3, 2026Insider · 3 peopleInsiders: 3 sales (~$2.7M)
- Mar 4, 2026InsiderOfficer sold ~$1.18M of ISRG shares in the open market
- Mar 5, 2026InsiderOfficer sold ~$321K of ISRG shares in the open market
- Mar 6, 2026InsiderOfficer sold ~$318K of ISRG shares in the open market
- Mar 9, 2026InsiderOfficer sold ~$313K of ISRG shares in the open market
- Mar 10, 2026InsiderOfficer sold ~$52K of ISRG shares in the open market
- Mar 11, 2026FDAFDA device clearance: da Vinci Force Feedback Instruments
- Mar 11, 2026FDARecall: Intuitive 8 mm SureForm 30 Gray Reloads Reference Numbers: 48230M-05 and 48230M-06
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 2, 2026FDARecall: Brand Name: Da Vinci X and Da Vinci Xi Product Name: da Vinci X, Xi Surgical System Model/Catalog Number: IS4000; IS4200 Software Version: N/A Product Descript…
- Apr 21, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 22, 2026FDARecall: Da Vinci ASSY, PSS, SP1098, Part Number: 380601
- Apr 24, 2026FDARecall: Brand Name: Da Vinci 5 Product Name: ASSY,DV5 TOWER,IS5000 Model/Catalog Number: 380746 Software Version: N/A Product Description: Preface: This report under 2…
- Apr 28, 2026InsiderDirector sold ~$237K of ISRG shares in the open market
- Apr 29, 2026InsiderDirector sold ~$55K of ISRG shares in the open market
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Intuitive Surgical
For Intuitive Surgical, OQRO holds 33 insider filings (SEC Form 4 or Form 144) and 5 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ISRG page.
Other recent filings by Rep. Gilbert Ray Cisneros Jr. (CA31)
- House Clerk periodic transaction report at Alexandria Real Estate Equities (ARE)Nov 10, 2026
- House Clerk periodic transaction report at Alliant Energy (LNT)Nov 10, 2026
- House Clerk periodic transaction report at AppLovin (APP)Nov 10, 2026
- House Clerk periodic transaction report at AppLovin (APP)Nov 10, 2026
- House Clerk periodic transaction report at Argenx (ARGX)Nov 10, 2026
The full history of Rep. Gilbert Ray Cisneros Jr. (CA31) is on the profile page.
How this filing works
Explore the data
Other disclosures at Intuitive Surgical
- SEC Form 13F-HRNov 13, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 144Nov 10, 2026
- SEC Form 4Nov 5, 2026
- SEC Form 4Nov 5, 2026
- SEC Form 144Nov 4, 2026
Everything OQRO holds on this company is on its ISRG page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
